Correlation Between CbdMD and Cannara Biotech
Can any of the company-specific risk be diversified away by investing in both CbdMD and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CbdMD and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between cbdMD Inc and Cannara Biotech, you can compare the effects of market volatilities on CbdMD and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CbdMD with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CbdMD and Cannara Biotech.
Diversification Opportunities for CbdMD and Cannara Biotech
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CbdMD and Cannara is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding cbdMD Inc and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and CbdMD is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on cbdMD Inc are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of CbdMD i.e., CbdMD and Cannara Biotech go up and down completely randomly.
Pair Corralation between CbdMD and Cannara Biotech
Given the investment horizon of 90 days cbdMD Inc is expected to under-perform the Cannara Biotech. But the stock apears to be less risky and, when comparing its historical volatility, cbdMD Inc is 1.22 times less risky than Cannara Biotech. The stock trades about -0.03 of its potential returns per unit of risk. The Cannara Biotech is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 58.00 in Cannara Biotech on September 2, 2024 and sell it today you would lose (7.00) from holding Cannara Biotech or give up 12.07% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
cbdMD Inc vs. Cannara Biotech
Performance |
Timeline |
cbdMD Inc |
Cannara Biotech |
CbdMD and Cannara Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CbdMD and Cannara Biotech
The main advantage of trading using opposite CbdMD and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CbdMD position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.CbdMD vs. CV Sciences | CbdMD vs. Trulieve Cannabis Corp | CbdMD vs. Curaleaf Holdings | CbdMD vs. Green Thumb Industries |
Cannara Biotech vs. Holloman Energy Corp | Cannara Biotech vs. cbdMD Inc | Cannara Biotech vs. Evolus Inc | Cannara Biotech vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |